| Adipose tissue | Cross-sectional analysis | Prospective analysis | |
---|---|---|---|---|
Non-progressors | Progressors | |||
n | 51 | 422 | 277 | 102 |
Male, n (%) | 33 (65) | 243 (58) | 171 (62) | 43 (42)c |
Age (years)a | 31 (23, 39) | 27 (23, 32) | 26 (22, 31) | 28 (24, 32)d |
Full heritage, n (%) | 37 (73) | 345 (82) | 217 (78) | 92 (90)e |
Body weight (kg)b | 94 (24) | 94 (23) | 91 (21) | 102 (22)f |
BMI (kg/m2)b | 33 (8) | 34 (8) | 33 (7) | 38 (7)f |
Body fat (%)b | 31 (8) | 33 (8) | 31 (8) | 36 (7)f |
FPG (mmol/l)b | 4.8 (0.5) | 5.0 (0.6) | 4.9 (0.6) | 5.2 (0.6)f |
2Â h-PG (mmol/l)b | 6.5 (1.8) | 6.9 (1.8) | 6.5 (1.6) | 7.9 (1.8)f |
NGR/IGR | 33/18 | 265/157 | 198/79 | 41/61 |
Fasting insulin—OGTT (pmol/L)a | 155 (89, 272) | 153 (76, 271) | 139 (69, 236) | 236 (132, 382)f |
M (mg kg −1EMBS  min−1)a | 2.80 (2.41, 3.86) | 2.29 (1.99, 2.87) | 2.48 (2.11, 3.19) | 2.03 (1.86, 2.64)f |
AIR (pmol/l)a | 1347 (860, 2309) | 1403 (917, 2132) | 1535 (1000, 2215) | 1264 (785, 1833)d |
EGP—basal (mg kg −1EMBS  min−1)b | 1.95 (0.35) | 2.45 (0.40) | 1.90 (0.24) | 1.91 (0.26) |
EGP—insulin (mg kg −1EMBS  min−1)a | 0.27 (0, 0.60) | 0.25 (0, 0.58) | 0.19 (0, 0.56) | 0.39 (0.15, 0.70)f |
Albumin (g/l)b | 39.6 (4.2) | 39.8 (4.2) | 40.2 (4.3) | 38.7 (3.6)f |